Vitality Watch

Dossier clinicaltrials trial early 10-sep-2026
Small or early-phase human trial or pilot study

Evaluation of Safety and Efficacy of a Digital Therapeutic Device to Improve Strength in Sarcopenia (Sarc-DTx)

Key claim: A clinical trial aims to show that the exoDTx digital therapeutic device is superior to self-exercise for improving muscle strength in people with sarcopenia, with acceptable safety.

Abstract

This clinical trial aims to demonstrate that the use of a digital therapeutic device (exoDTx) in patients with sarcopenia is superior to self-exercise in terms of muscle strength improvement and safety.

Why this matters

A clinical trial aims to show that the exoDTx digital therapeutic device is superior to self-exercise for improving muscle strength in people with sarcopenia, with acceptable safety.

Source

Link

Briefing card

Evaluation of Safety and Efficacy of a Digital Therapeutic Device to Improve Strength in Sarcopenia (Sarc-DTx)
Stage: trial early · clinicaltrials · 10-sep-2026

A clinical trial aims to show that the exoDTx digital therapeutic device is superior to self-exercise for improving muscle strength in people with sarcopenia, with acceptable safety.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: nct:NCT07319377

build build 880 · 2bcef25 · 2026-11-18